evimatic
  • HOW IT WORKS
  • ABOUT ADHD
  • FOR USERS
    • Support material
  • ABOUT US
    • Team
  • BLOG
  • Contact
  • en_GB
    • ca
    • es_ES
  • Start Now
Select Page
Evimatic® recognized with the ITEMAS seal of quality

Evimatic® recognized with the ITEMAS seal of quality

Oct 22, 2024 | Notícies

The Evimatic® project has been recognized with the ITEMAS seal of quality, the revitalization and innovation platform of the Instituto de Salud Carlos...
Evimatic® selected to be part of the ITEMS portfolio

Evimatic® selected to be part of the ITEMS portfolio

Oct 22, 2024 | Notícies

Evimatic® has been selected to be part of the ITEMAS portfolio, the revitalization and innovation platform of the Instituto de Salud Carlos...
We won the first Mental Health Investment Forum award

We won the first Mental Health Investment Forum award

Feb 15, 2024 | Notícies

We presented Evimatic® at the II Mental Health Innovation Contest organized by the TECSAM network and BHV partners and won the first Mental Health Investment Forum prize sponsored by the venture building consultancy BHV...
  • General information about ADHD
  • Treatment of ADHD
  • Selection of outcomes (therapeutic goals)
  • Therapeutic objectives
    • Symptoms of ADHD
    • Improved clinical global impression
    • Preventing drug or substance use disorder
    • Decreasing drug use
    • Accident prevention
    • Improved academic performance
    • Quality of life
  • Adverse side effects
    • Loss of appetite
    • Insomnia
    • Drowsiness
    • Dizziness
    • Dry mouth
    • Tics
    • Seizures
    • Vomiting
    • Fainting
    • Stopping treatment because of adverse side effects
  • Acceptability
© 2024 Universitat de Girona. All rights reserved. | Legal notice and data protection
en_GB
en_GB
ca
es_ES